Among them, the NR3C1-encoded glucocorticoid receptor (GR) was selected because its available agonist and antagonist used in clinical practice and its expression level were elevated in the MD tissue compared to the normal counterpart (Supplementary Fig. 6a). This evidence concerns the gene NR3C1 and Menkes disease.